Novadip Biosciences Raises Funds to Support Regenerative Tissue Products

Nov 7, 2022 | Featured News

Novadip Biosciences raised an additional €40 million (~USD $40 million) in a Series B equity round and non-dilutive funding. This brings the company’s total funding to €88 million, to date.